Objectives: Monitoring regional levels of transmitted HIV-1 resistance informs treatment
guidelines and provides feedback on the success of HIV-1 prevention efforts. Surveillance …

Abstract The European HIV Drug Resistance Guidelines Panel, established to make
recommendations to clinicians and virologists, felt that sufficient new information has …

Interpreting the results of plasma human immunodeficiency virus type 1 (HIV-1) genotypic
drug-resistance tests is one of the most difficult tasks facing clinicians caring for HIV-1 …

Abstract The Stanford HIV Drug Resistance Database hosts a freely available online
genotypic resistance interpretation system called HIVdb to help clinicians and laboratories …

Abstract The Human Immunodeficiency Virus (HIV) is a complex retrovirus that progressively
deteriorates the immune system of infected patients, eventually causing death. Although …

In most European countries, HIV drug resistance testing has become a routine clinical tool.
However, its practical implementation in a clinical context is demanding. The European HIV …

Background The evolution of drug-resistant viruses challenges the management of human
immunodeficiency virus (HIV) infections. Understanding this evolutionary process is …

The major limitation of drug resistance genotyping for human immunodeficiency virus
remains the interpretation of the results. We evaluated the concordance in predicting therapy …

A series of 2-(1 H-indol-3-yl) ethylthiourea derivatives were prepared by condensation of 2-
(1 H-indol-3-yl) ethanamine with appropriate aryl/alkylisothiocyanates in anhydrous media …

Programmes that monitor local, national and regional levels of transmitted HIV-1 drug
resistance inform treatment guidelines and provide feedback on the success of HIV-1 …